IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

DONGIOVANNI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12092
NA - Nord America 6948
AS - Asia 3035
SA - Sud America 139
AF - Africa 52
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 13
Totale 22324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6752
GB - Regno Unito 5870
CN - Cina 1725
DE - Germania 1574
IT - Italia 1415
SE - Svezia 1073
RU - Federazione Russa 426
IE - Irlanda 377
TR - Turchia 317
UA - Ucraina 309
KR - Corea 281
FR - Francia 262
IN - India 206
FI - Finlandia 178
CA - Canada 153
NL - Olanda 138
JP - Giappone 127
EU - Europa 124
PL - Polonia 119
DK - Danimarca 98
BE - Belgio 82
CO - Colombia 77
IR - Iran 61
VN - Vietnam 56
TW - Taiwan 47
AU - Australia 45
ID - Indonesia 43
BR - Brasile 41
HK - Hong Kong 37
MX - Messico 35
GR - Grecia 34
RO - Romania 31
EG - Egitto 29
CH - Svizzera 22
ES - Italia 22
SG - Singapore 22
PK - Pakistan 19
AT - Austria 14
UZ - Uzbekistan 14
AR - Argentina 12
PT - Portogallo 11
NO - Norvegia 10
TH - Thailandia 10
HU - Ungheria 8
KE - Kenya 8
IL - Israele 7
MY - Malesia 7
PH - Filippine 7
SA - Arabia Saudita 6
BD - Bangladesh 5
CZ - Repubblica Ceca 5
MN - Mongolia 5
QA - Qatar 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CL - Cile 4
GE - Georgia 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
HR - Croazia 3
LK - Sri Lanka 3
PA - Panama 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AM - Armenia 2
CM - Camerun 2
CV - Capo Verde 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
MU - Mauritius 2
RS - Serbia 2
SC - Seychelles 2
SD - Sudan 2
TN - Tunisia 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BT - Bhutan 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
HN - Honduras 1
IM - Isola di Man 1
LT - Lituania 1
PS - Palestinian Territory 1
PY - Paraguay 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 22440
Salva come PNG Salva come JPEG
Città #
Southend 5643
Chandler 835
Hanover 737
Milan 681
Seattle 600
Fairfield 510
Wilmington 445
Princeton 435
Beijing 376
Dublin 370
Dearborn 280
Houston 280
Ann Arbor 279
Ashburn 265
Jacksonville 251
Woodbridge 232
Nanjing 181
Cambridge 175
Munich 145
Mountain View 142
Des Moines 139
Redmond 135
Toronto 118
Andover 112
Redwood City 105
Warsaw 105
Serra 99
Boardman 96
Sakarya 93
Phoenix 91
Hangzhou 88
Shanghai 79
Jinan 75
Bogotá 74
Somerville 74
Guangzhou 70
Shenyang 67
Sunnyvale 65
Brussels 56
Changsha 56
Nanchang 53
Grafing 43
Taipei 40
Tianjin 39
Chengdu 37
Hebei 35
Jiaxing 35
Falls Church 34
San Diego 34
Saint Petersburg 33
Wuhan 33
Berlin 32
Pisa 32
Turin 29
Chicago 27
Rome 27
Silver Spring 27
Tokyo 27
Kunming 26
Odernheim 25
Istanbul 24
Suzhou 23
Bitonto 22
Dong Ket 22
Athens 21
London 20
Margão 20
Seoul 20
Ningbo 18
Nürnberg 18
Pusan 18
Verona 18
Zhengzhou 18
Central District 17
Medford 17
Hamburg 16
Hefei 16
Los Angeles 16
São Paulo 16
Fremont 15
New York 15
Singapore 15
Delhi 14
Fuzhou 14
Lanzhou 14
Taizhou 14
Xian 14
Auburn Hills 13
Palaiseau 12
Portici 12
Taiyuan 12
Duncan 11
Gurgaon 11
Helsinki 11
Mumbai 11
Norwalk 11
Ottawa 11
Cupertino 10
Edinburgh 10
Noginsk 10
Totale 15947
Salva come PNG Salva come JPEG
Nome #
The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development : a potential therapeutic target? 444
Statin use and nonalcoholic steatohepatitis in at risk individuals 332
PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma 303
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 301
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver 300
The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation 292
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 273
Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis 254
PNPLA3 I148M polymorphism and progressive liver disease 251
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 230
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 216
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression : An Observational Study in Patients with Nonalcoholic Fatty Liver Disease 215
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 209
DIETARY IRON OVERLOAD INDUCES VISCERAL ADIPOSE TISSUE INSULIN RESISTANCE: SYNERGY WITH OBESITY IN INDUCING SYSTEMIC INSULIN RESISTANCE 204
The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease 200
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 199
Epicardial Adipose Tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease 197
High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload 195
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 191
Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease 191
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 187
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C 185
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients : TMPRSS6 and hepcidin in hemodialysis 181
Dietary iron overload induces visceral adipose tissue insulin resistance and hyper-resistinemia, and synergizes with obesity and fatty liver in inducing systemic insulin resistance 176
β-Klotho gene variation is associated with liver damage in children with NAFLD 176
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 174
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations 170
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease 169
The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls 168
MAFLD in COVID-19 patients: an insidious enemy 168
α1-Antitrypsin mutations in NAFLD : high prevalence and association with altered iron metabolism but not with liver damage 167
Liver fat accumulation is associated with circulating PCSK9 levels 162
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 160
Genetic factors in the pathogenesis of nonalcoholic fatty liver and steatohepatitis 160
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with non-alcoholic fatty live 157
Impact Of Iron Overload On Reproductive Axis Impairment: Pathophysiological Insights From In Vitro And In Vivo Studies 157
Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease 152
TRB3 is associated with hepatic lipogenesis and dyslipidemia in NAFLD 151
A drug transporter gene polymorphism predicts renal tubular toxicity in patients with chronic hepatitis B on long-term adefovir and lamivudine combination 151
Dietary iron overload induces visceral adipose tissue insulin resistance 151
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 151
Effect of iron depletion by phlebotomy on insulin resistance in patients with non alcoholic fatty liver disease and hyperferritinemia : evidence from a case control study 150
PNPLA3 I148M polymorphism, etiology, and clinical features of hepatocellular carcinoma 150
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 148
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 147
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD 147
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance 146
Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study 145
Serum ferritin, is associated with iron availability, decreased anti-oxidant potemtial and HFE gene mutations, and a risk factor for cardiovascular damage in hemodialysis patients 144
Iron status modulates the expression of the ubiquitin ligase mdm-2 and of its target p53 in mouse hepatocytes and primary human monocytes 144
Dietary iron overload induces visceral adipose tissue insulin resistance associated with hyper-resistinemia, and synergizes with obesity and fatty liver in inducing systemic insulin resistance 143
Increased circulating adiponectin in males with chronic HCV hepatitis 143
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 143
Iron stores, hepcidin, and aortic stiffness in individuals with hypertension 142
A1-antitripsin mutations are associated with altered iron metabolism but not liver damage in non alcoholic fatty liver disease 140
NPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 140
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease 138
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease 137
Homozygosity for the PNPLA3/Adiponutrin I148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 136
Homozygosity for the PNPLA3/Adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 136
Interaction between the PNPLA3 I148M mutation and body weight in determining steatosis and the progression to cirrhosis in hereditary hemochromatosis 136
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 136
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 135
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C 135
Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes : evidence in NAFLD patients and cell cultures 134
Increased prevalence of PIS Alpha1-antitrypsin allele in italian patients with non alcoholic fatty liver disease 133
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 133
PNPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 132
TNF alpha promoter polymorphisms in Italian patients with porphyria cutanea tarda 130
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease 129
MiRNA signature in NAFLD: A turning point for a non-invasive diagnosis 129
Increased prevalence of PIS Alpha1-antitrypsin allele in italian patients with non-alcoholic fatty liver disease 128
PNPLA3/adiponutrin genotype is strongly associated with metabolic syndrome components and liver damage in patients with non-alcoholic fatty liver disease 127
Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease : a case control study 126
Can nonalcoholic steatohepatitis trigger porphyria cutanea tarda clinical manifestations? 125
Dietary iron overload induces visceral adipose tissue insulin resistance associated with hyper-resistinemia, and synergizes with obesity in inducing systemic insulin resistance 124
TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis 123
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease 123
Iron status modulates the expression of the ubiquitin ligase mdm-2 and of its target p53 in mouse hepatocytes and primary human monocytes 122
Iron depletion by phlebotomy improves liver transaminases in patients with nonalcoholic fatty liver disease : a propensity score adjusted analysis 122
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system 121
Relative contribution of iron genes, dysmetabolism and hcv in the pathogenesis of altered iron regulation in chronic hepatitis C 120
FGF23 and Fetuin-A interaction in the liver and in the circulation 120
Iron affect glucose metabolismi in hepatocytes by regulating insulin receptor expression and glucose uptake 119
A novel alpha1-antitrypsin null variant (PiQ0Milano) 119
Particulate matter phagocytosis induces tissue factor in differentiating macrophages 118
Iron and insulin resistance 117
Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B 117
Inherited variants of genes involved in insulin signaling affect the risk of hepatic fibrosis in NAFLD 116
Drug transporter gene polymorphism predicts renal tubular toxicity in patients with chronic hepatitis B on long-term adefovir and lamivudine combination 116
Liver fat accumulation is associated with circulating PCSK9 116
Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations 115
Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis 115
Increased expression of the forkihead transcription factor foxo1 associated with gluconeogenesis and insulin resistance in non-alcoholic steatohepatitis 114
TNFalpha promoter polymorphisms 114
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis 114
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease 113
Iron genes, dysmetabolism and fibrosis in chronic hepatitis C 112
Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver 112
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia 111
Totale 16090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37758
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018126 0000 00 00 000126
2018/20192863 607176167278 53244 26377 187317254240
2019/20203816 355143138583 194576 369338 455360173132
2020/20213275 148238204150 269232 266185 319336605323
2021/20223909 293141220390 311304 332291 431338343515
2022/20233310 393326306292 375661 106241 3436419013
Totale 23878